Omega-3 Fatty Acids (EPA/DHA)

Omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are essential polyunsaturated fats primarily found in marine sources. Research indicates these compounds play crucial roles in cardiovascular health, with studies suggesting they may help reduce triglyceride levels, support healthy blood pressure, and decrease inflammation markers. Large-scale trials like the VITAL study have shown mixed but generally positive results for cardiovascular protection, particularly in populations with lower baseline omega-3 intake.

Studies suggest omega-3s may also support brain health and cognitive function throughout the lifespan. Research indicates DHA is particularly concentrated in brain tissue and may help maintain neuronal membrane integrity and support neurotransmitter function. Some trials have shown potential benefits for mood regulation and cognitive decline in aging populations, though results vary based on dosage, duration, and participant characteristics.

The research profile for omega-3 supplementation is extensive, with decades of human trials examining various health outcomes. While not all studies show uniform benefits, the overall evidence suggests omega-3 supplementation may be particularly beneficial for individuals with low dietary fish intake, elevated triglycerides, or inflammatory conditions. Quality and bioavailability can vary significantly between products, with factors like EPA/DHA ratio, molecular form, and purity affecting research outcomes.